Are High-CBD Hemp Flowers the Next Big Thing in Cannabis?

hempyyy

Photo by: Remedy Review

Pirate (not his real name) has been working with cannabis his entire adult life, a trajectory that took him from getting his fingernails dirty at a clandestine outdoor grow in the underground economy to serving patients as part of California’s gray market in medical marijuana, and then on into a job at a state-licensed cannabis dispensary.

So he’s kinda seen it all.

Except now he’s in a whole new field—an Oregon hemp field to be exact—working for a company that grows, markets, and distributes a product you probably haven’t encountered yet. But you may soon, because 2019 is going to be a bumper crop for high-CBD hemp flower.

“It’s mind-blowing,” Pirate tells me. “Some of my mentors from when I was an outdoor grower are now asking for advice on how to set themselves up as CBD hemp farmers.”

Now, no doubt you’ve heard plenty about CBD by now. It’s trendy! It’s helps children with severe seizure disorders. It’s in capsules, oils, vape pens, gummies, coffee, salves, rubs, and lotions. Hell, it’s even been infused into a corporate hamburger!

Continue reading “Are High-CBD Hemp Flowers the Next Big Thing in Cannabis?”

7 Pioneers of Cannabis’ CBD Movement

cbd pio.png

For this reason, it’s important to pay homage to the chemists, breeders, and growers who have spearheaded the development of CBD strains and medicines. These are the pioneers who brought something new and different to the world of cannabis.

Continue reading “7 Pioneers of Cannabis’ CBD Movement”

Morgan Stanley: DEA Likely To Reclassify GW Pharma’s Cannabinoid Therapy For US Launch

gw

By Sunday night, the U.S. Drug Enforcement Administration is expected to reclassify GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH)’s Epidiolex to allow medicinal use. This could open the therapy to a new and promising market.

Continue reading “Morgan Stanley: DEA Likely To Reclassify GW Pharma’s Cannabinoid Therapy For US Launch”